Trump administration finalizes rule to end federal support for gender-affirming care
Summary
The Trump administration finalized a rule to stop federal funding for gender-affirming care through Medicaid and the Children’s Health Insurance Program (CHIP). This change will affect children who receive this type of healthcare and has sparked legal challenges that may delay or block the rule.Key Facts
- The rule ends federal support for gender-affirming care for children through Medicaid and CHIP starting October 13.
- Nearly 90% of the 35,000 public comments opposed this change when it was proposed in December.
- Gender-affirming care includes treatments like puberty blockers, hormones, medical monitoring, and sometimes surgery.
- The Department of Health and Human Services (HHS) cited international reviews supporting the rule but did not include recent studies showing the safety and benefits of gender-affirming care.
- Advocacy groups say the rule is based on ideology, not medical evidence, and harms transgender youth.
- States or private organizations might still provide gender-affirming care using non-federal funds.
- Legal action has been taken against the administration, including a class-action lawsuit filed by federal employees and their families.
- A previous attempt to penalize healthcare providers who offer gender-affirming care was stopped by a federal judge.
Read the Full Article
This is a fact-based summary from The Actual News. Click below to read the complete story directly from the original source.
